Search results

The study research aims to examine the effects of supply chain management practices on risk mitigating (RM) by studying the correlation between social ties, institutional support, interagency cooperation and external flexibility in public healthcare sectors. Moreover, this research examines the impact of RM on supplier trust, and also the authors examine the relationship among supplier trust and logistics performance.

The authors used a structural equation model (SEM) based on 539 quantitative data from Ethiopian healthcare organizations. The model included control variables like company size and position to understand better how employees perceive risk mitigation.

The study's findings indicate that interagency collaboration and external flexibility positively affects RM. On the other hand, RM positively impacts supplier trust and also the supplier trust has a positive effects on performance dimensions. This study also shows that RM has not positively impacting institutional support and social ties.

The study investigation may help the pharmaceutical industry, healthcare service SC agencies and other stakeholders better understand the effects of supply chain management practices on RM and obtain information on progress made thus far.

This research helps managers and their organizations to manage the risk associated with their organizations. Though, this study focuses on Ethiopian healthcare SCM. The authors expect the findings might apply to other countries organizations with comparable demographic or SCM features.

This study aims to understand better how business strategies impact a company’s corporate social responsibility (CSR).

In this research, two categories of business strategy are proposed, and partial least squares structural equation modelling (PLS-SEM) was used to test the research model using a sample of 150 valid surveys data from the Chinese manufacturing firms industry in Africa.

This study indicates business strategy in terms of real support and development approach plan in the Chinese manufacturing industry has a crucial influence on CSR effectiveness. Business strategy leads to effective CSR practices by adding value to firm products, services, marketing strategies and technological investment.

Companies can use a support strategy for effective CSR to improve corporate social performance. The study expands upon previous insights into corporate leaders enhancing their CSR strategy because it may successfully contribute to environmental preservation.

This research mobilized and found academic gaps in business strategy regarding real support and development approach; it is necessary to combine the impacts of business strategy at multiple levels of analysis to explain the expansion of CSR to integrate the stakeholder theory.

This study offers a deeper perspective and provides empirical evidence of a better understanding of CSR effectiveness by emphasizing the role of business strategy. Effective CSR implementation requires integrating the influences of company strategy and real support at multiple levels of analysis to explain CSR dispersion.

The coronavirus disease 2019 (COVID-19) pandemic represents one of the most significant disruptions to supply chains (SCs), stimulating both practitioners and scholars to seek ways to enhance supply chain performance (SCP). Recent advancements in technology, particularly supply chain analytics (SCA) technologies, offer promising avenues for mitigating risks associated with SC disruptions like those posed by the COVID-19 pandemic. However, the existing literature lacks a comprehensive analysis of the connection between SCA and healthcare SC (HSC) performance. To address this research gap, we employed the dynamic capability perspective to investigate the mediating roles of supply chain innovation (SCI), resilience (SCR) and flexibility (SCF) in the relationship between SCA and HSC performance. The study further examined the moderating role of a data-driven culture (DDC).

The proposed model was tested using survey data from 374 managers of healthcare facilities in Ghana. SPSS and Amos were used to analyze the data gathered.

The results showed that while SCA may drive HSC performance, the presence of SCI, SCR and SCF may serve as channels to drive enhanced HSC performance. Additionally, we also found that different levels of a DDC induce varying effects of SCA on SCI, SCR and SCF.

The study’s results have theoretical and practical implications, offering valuable insights for the advancement of SCA in healthcare literature. They also deepen SC managers’ comprehension of how and when SCA can boost HSC performance. However, as the study was limited to healthcare facilities in Ghana, its findings may not be universally applicable.

This study contributes to the literature by demonstrating that SCI, SCR, SCF and a DDC could serve as transformative mechanisms to reap superior HSC outcomes. This study also offers contemporary guidance to managers regarding SCA investment decisions.